SEC Form 4 · accession 0001553878-16-000057
ALNYLAM PHARMACEUTICALS, INC. · ALNY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John Maraganore
Officer — Chief Executive Officer · Director
Period of report
Oct 12, 2016
Accepted (ET)
Oct 14, 2016 · 4:17 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001178670
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Oct 12, 2016 | M | 3,521 | $7.10 | A | 136,910 | D | |
| Common Stock | Oct 12, 2016 | M | 4,019 | $18.66 | A | 140,929 | D | |
| Common StockF1 | holding | — | — | — | 2,841 | I | By Managed Account |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $7.10 | Oct 12, 2016 | M | 3,521 | D | — | Nov 30, 2021 | Common Stock | 3,521 | 135,915 | D |
| Stock Option (Right to Buy)F2 | $18.66 | Oct 12, 2016 | M | 4,019 | D | — | Dec 20, 2022 | Common Stock | 4,019 | 145,981 | D |
Explanation of responses
- F1The reporting person owns 2,841 shares of ALNY common stock under the ALNY 401(k) plan as a result of the ALNY 401(k) matching contribution program.
- F2The stock option vests as to 25% of the shares on the first anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter.